PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 121 filers reported holding PRINCIPIA BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $94,520,000 | -18.6% | 1,580,873 | -19.2% | 0.42% | -41.7% |
| Q1 2020 | $116,112,000 | +18.5% | 1,955,413 | +9.4% | 0.72% | +37.2% |
| Q4 2019 | $97,944,000 | +109.7% | 1,787,957 | +8.1% | 0.52% | +63.8% |
| Q3 2019 | $46,710,000 | -21.3% | 1,654,029 | -7.5% | 0.32% | -21.1% |
| Q2 2019 | $59,337,000 | -2.4% | 1,787,807 | 0.0% | 0.40% | +3.6% |
| Q1 2019 | $60,785,000 | +24.1% | 1,787,807 | 0.0% | 0.39% | -3.0% |
| Q4 2018 | $48,968,000 | -6.3% | 1,787,807 | 0.0% | 0.40% | +16.6% |
| Q3 2018 | $52,240,000 | – | 1,787,807 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |